Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Advances in Therapy|June 21, 2025
Matching-Adjusted Indirect Comparison of Sotorasib Versus Adagrasib in Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer Harboring KRAS G12C MutationDivyan Chopra, Zhiyi Lan, David M Waterhouse, et al.
Drugs - Real World Outcomes|July 30, 2020
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung CancerDavid M Waterhouse, Janet L Espirito, Marc D Chioda, et al.
Future Oncology (London, England)|March 26, 2021
Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice settingDavid M Waterhouse, Esmond D Nwokeji, Marley Boyd, et al.
Cancer Investigation|April 26, 2013
Sorafenib and everolimus in advanced clear cell renal carcinoma: a phase I/II trial of the SCRI Oncology Research ConsortiumJohn D Hainsworth, David M Waterhouse, William C Penley, et al.
The Oncologist|December 8, 2009
Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary siteJohn D Hainsworth, David R Spigel, Dana S Thompson, et al.
JCO Oncology Practice|October 2, 2024
State of Geographic Access to Cancer Treatment Trials in the United States: Are Studies Located Where Patients Live?M Kelsey Kirkwood, Caroline Schenkel, Dominique C Hinshaw, et al.
Clinical Breast Cancer|November 26, 2009
Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancerDenise A Yardley, Howard A Burris, Tiffanie Markus, et al.
Frontiers in Oncology|December 19, 2019
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With <i>nab</i>-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung CancerJonathan W Goldman, David M Waterhouse, Ben George, et al.
Breast Cancer Research and Treatment|December 11, 2012
Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimenDenise A Yardley, Lowell Hart, Linda Bosserman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trialDavid R Spigel, Peter M Townley, David M Waterhouse, et al.
Pageof 5